Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.arcmed.2020.05.020 http://scihub22266oqcxt.onion/10.1016/j.arcmed.2020.05.020 32532524!7260490!32532524     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Arch+Med+Res 2020 ; 51 (6): 589-592 Nephropedia Template TP {{tp|p=32532524|t=2020. SARS-CoV-2-A Tough Opponent for the Immune System |pdf=|usr=}}{{32532524}} gab.com Text SARS-CoV-2-A Tough Opponent for the Immune System JO: Arch Med Res http://www.kidney.de/pget.php?&tw=1&pmid=32532524 #FOAvip Coronaviruses recently returned with a new one, SARS-CoV-2, related to a potentially severe respiratory disease-called the coronavirus disease (COVID-19). Research shows that the SARS-CoV-2 can be clustered with the Bat SARS-like coronavirus. Bats possess an additional, innate ability for antiviral defense, and, on the other hand, the potential to go hand-in-hand with the virus to generate variability. Besides the high potential of the novel coronavirus in compromising the respiratory system, its rapid transmission and ability to engage many hosts in severe forms of infections or immunopathological complications make it a tough opponent for the immune system. The interactions between SARS-CoV2 and the host immune system result in unleashing tremendous amounts of cytokines, and these cytokines make a storm that would determine the outcome (recovery or death) of the lungs of the patient. Twit Text FOAVip SARS-CoV-2-A Tough Opponent for the Immune System ????Arch Med Res http://www.kidney.de/pget.php?&tw=1&pmid=32532524 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32532524 #FOAvip English Wikipedia <ref>{{Cite pmid|32532524}}</ref> SARS-CoV-2-A Tough Opponent for the Immune System #MMPMID32532524 Nasab MG; Saghazadeh A; Rezaei N Arch Med Res 2020[Aug]; 51 (6): 589-592 PMID32532524show ga Coronaviruses recently returned with a new one, SARS-CoV-2, related to a potentially severe respiratory disease-called the coronavirus disease (COVID-19). Research shows that the SARS-CoV-2 can be clustered with the Bat SARS-like coronavirus. Bats possess an additional, innate ability for antiviral defense, and, on the other hand, the potential to go hand-in-hand with the virus to generate variability. Besides the high potential of the novel coronavirus in compromising the respiratory system, its rapid transmission and ability to engage many hosts in severe forms of infections or immunopathological complications make it a tough opponent for the immune system. The interactions between SARS-CoV2 and the host immune system result in unleashing tremendous amounts of cytokines, and these cytokines make a storm that would determine the outcome (recovery or death) of the lungs of the patient. |*Betacoronavirus[MESH] |Animals[MESH] |Antiviral Agents[MESH] |COVID-19[MESH] |COVID-19 Vaccines[MESH] |Chiroptera[MESH] |Coronavirus Infections/*immunology/prevention & control/virology[MESH] |Cytokines/immunology[MESH] |Epitopes/immunology[MESH] |Humans[MESH] |Immune System/*virology[MESH] |Lung/immunology/pathology/*virology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*immunology/virology[MESH] |SARS-CoV-2[MESH] |Viral Vaccines[MESH]SARS-CoV-2-A Tough Opponent for the Immune System (epmc).pdf DeepDyve Pubget Overpricing